Australia-wide dispatch Australia Post Express tracked 12 business days Research-grade COA-verified HPLC purity data manufacturer CoA Crypto payment BTC LTC XMR researcher privacy by design RetaLABS BPC-157 / TB-500 Blend combines two of the most researched tissue-repair peptides into a single lyophilised vial, providing 5mg BPC-157 and 5mg TB-500 (Thymosin Beta-4 fragment) per vial
Retatrutide clinical trial results The phase 2 trial, published in the New England Journal of Medicine, tested retatrutide at doses ranging from 1 mg to 12 mg weekly in adults with obesity
Medically reviewed by Michael Casnellie, MD, Jaideep Chunduri, MD, David McConda, MD, and Steven Ganzel, DO
A small open-label pilot (N=20) published in 2000 tested GHK-Cu-containing wound dressings on post-surgical and chronic wounds
Their entire bodies may feel sore, drained, and overall in need of relief